Sun Haitao1, Wang Yao1, Jiang Xin2, Cai Xiaopan1, Wang Ting1, Lou Yan1, Zhao Chenglong3, Wu Zhipeng4, Xiao Jianru5. 1. Spine Tumor Center, Department of Orthopedic Oncology, Changzheng Hospital, No. 415 Fengyang Road, Huangpu District, Shanghai, China. 2. Department of Anesthesiology, Changzheng Hospital, Shanghai, China. 3. Spine Tumor Center, Department of Orthopedic Oncology, Changzheng Hospital, No. 415 Fengyang Road, Huangpu District, Shanghai, China. 18501646030@163.com. 4. Spine Tumor Center, Department of Orthopedic Oncology, Changzheng Hospital, No. 415 Fengyang Road, Huangpu District, Shanghai, China. eaglewzp@163.com. 5. Spine Tumor Center, Department of Orthopedic Oncology, Changzheng Hospital, No. 415 Fengyang Road, Huangpu District, Shanghai, China. cz_xiaojianru@163.com.
Abstract
INTRODUCTION: Spinal ganglioneuroma (GN) is the most benign neoplasm of neuroblastic origin. There is little knowledge about spinal GN because of sporadic cases reported. The objective of this study is to describe the clinical manifestations and long-term follow-up outcomes of spinal GN after consecutive treatment. METHODS: The clinical and follow-up data of 31 patients with spinal GN receiving consecutive treatment in our institute are retrospectively analyzed. RESULTS: The mean age of the 31 patients was 40.39 ± 14.8 years. They were diagnosed with spinal GN and received surgical treatment in our institution between February 2012 and August 2019. Of them, 22 (71%) patients presented preoperative neurological symptoms. The mean duration from symptom onset to surgery was 19.76 ± 49.59 months. Eighteen patients received complete surgical resection and 13 patients received subtotal excision. In addition, radicotomy was performed simultaneously after sophisticated consideration in 19 patients. The follow-up period averaged 64.13 ± 22.67 months. The preoperative neurological dysfunction was improved significantly during the follow-up period in all cases. No local recurrence or malignant transformation has occurred so far. CONCLUSION: Spinal GN is a rare but benign neoplasm, and the origin of spinal GN remains controversial. With our experience, we propose that the origin of spinal GN from dorsal root ganglion should be equally considered as its counterpart of sympathetic ganglion. Complete resection is the preferred surgical strategy to avoid malignant events and recurrence. And the close postoperative follow-up observations are warranted.
INTRODUCTION:Spinal ganglioneuroma (GN) is the most benign neoplasm of neuroblastic origin. There is little knowledge about spinal GN because of sporadic cases reported. The objective of this study is to describe the clinical manifestations and long-term follow-up outcomes of spinal GN after consecutive treatment. METHODS: The clinical and follow-up data of 31 patients with spinal GN receiving consecutive treatment in our institute are retrospectively analyzed. RESULTS: The mean age of the 31 patients was 40.39 ± 14.8 years. They were diagnosed with spinal GN and received surgical treatment in our institution between February 2012 and August 2019. Of them, 22 (71%) patients presented preoperative neurological symptoms. The mean duration from symptom onset to surgery was 19.76 ± 49.59 months. Eighteen patients received complete surgical resection and 13 patients received subtotal excision. In addition, radicotomy was performed simultaneously after sophisticated consideration in 19 patients. The follow-up period averaged 64.13 ± 22.67 months. The preoperative neurological dysfunction was improved significantly during the follow-up period in all cases. No local recurrence or malignant transformation has occurred so far. CONCLUSION: Spinal GN is a rare but benign neoplasm, and the origin of spinal GN remains controversial. With our experience, we propose that the origin of spinal GN from dorsal root ganglion should be equally considered as its counterpart of sympathetic ganglion. Complete resection is the preferred surgical strategy to avoid malignant events and recurrence. And the close postoperative follow-up observations are warranted.
Authors: Varatharaj Mounasamy; Mihir M Thacker; Scott Humble; Michel E Azouz; J David Pitcher; Sean P Scully; H Thomas Temple; Frank Eismont Journal: Skeletal Radiol Date: 2005-11-29 Impact factor: 2.199